164 related articles for article (PubMed ID: 33409796)
1. Magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation.
Dong X; Luo J; Lan P; Guo X; Zhao X; Wang X; Zhou F; Wang Q; Yuan H; Sun J
Eur Radiol; 2021 Jul; 31(7):4615-4624. PubMed ID: 33409796
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium-Loaded Solid Lipid Nanoparticles for Colorectal Tumor in MR Colonography.
Wang H; Ding W; Peng L; Fan H; Yan C; Xu S; Sun J; Zhu X
J Biomed Nanotechnol; 2020 May; 16(5):594-602. PubMed ID: 32919480
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium-Loaded Solid Lipid Nanoparticles as a Tumor-Absorbable Contrast Agent for Early Diagnosis of Colorectal Tumors Using Magnetic Resonance Colonography.
Sun J; Zhang S; Jiang S; Bai W; Liu F; Yuan H; Ji J; Luo J; Han G; Chen L; Jin Y; Hu P; Yu L; Yang X
J Biomed Nanotechnol; 2016 Sep; 12(9):1709-23. PubMed ID: 29345451
[TBL] [Abstract][Full Text] [Related]
4. Development of a Novel MR Colonography via Iron-Based Solid Lipid Nanoparticles.
Wang H; Wang S; Zhu X; Ding W; Shen T; Fan H; Zhang Y; Peng L; Yuan H; Liu X; Ling J; Sun J
Int J Nanomedicine; 2022; 17():821-836. PubMed ID: 35228799
[TBL] [Abstract][Full Text] [Related]
5. Development of nanoparticle-based magnetic resonance colonography.
Sun J; Zheng W; Zhang H; Wu T; Yuan H; Yang X; Zhang S
Magn Reson Med; 2011 Mar; 65(3):673-9. PubMed ID: 21337401
[TBL] [Abstract][Full Text] [Related]
6. Bimodal visualization of colorectal uptake of nanoparticles in dimethylhydrazine-treated mice.
Wu T; Zheng WL; Zhang SZ; Sun JH; Yuan H
World J Gastroenterol; 2011 Aug; 17(31):3614-22. PubMed ID: 21987608
[TBL] [Abstract][Full Text] [Related]
7. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
Kuo YT; Chen CY; Liu GC; Wang YM
PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
[TBL] [Abstract][Full Text] [Related]
9. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
Guo YM; Liu M; Yang JL; Guo XJ; Wang SC; Duan XY; Wang P
Chin Med J (Engl); 2007 Jan; 120(1):50-5. PubMed ID: 17254488
[TBL] [Abstract][Full Text] [Related]
10. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA.
Runge VM
J Comput Assist Tomogr; 1998; 22(4):643-50. PubMed ID: 9676461
[TBL] [Abstract][Full Text] [Related]
11. Contrast enhancement of the brain by folate-conjugated gadolinium-diethylenetriaminepentaacetic acid-human serum albumin nanoparticles by magnetic resonance imaging.
Korkusuz H; Ulbrich K; Bihrer V; Welzel K; Chernikov V; Knobloch T; Petersen S; Huebner F; Ackermann H; Gelperina S; Korkusuz Y; Kromen W; Hammerstingl R; Haupenthal J; Fiehler J; Zeuzem S; Kreuter J; Vogl TJ; Piiper A
Mol Imaging; 2012; 11(4):272-9. PubMed ID: 22954143
[TBL] [Abstract][Full Text] [Related]
12. Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.
Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Hübner F; Waidmann O; Zeuzem S; Korf HW; Terfort A; Gelperina S; Vogl TJ; Kreuter J; Piiper A
J Control Release; 2015 Feb; 199():63-71. PubMed ID: 25499552
[TBL] [Abstract][Full Text] [Related]
13. Normal bladder wall morphology in Gd-DTPA-enhanced clinical MR imaging using an endorectal surface coil and histological assessment of submucosal linear enhancement using [14C]Gd-DOTA autoradiography in an animal model.
Takeda K; Kawaguchi T; Shiraishi T; Kobayashi S; Hayashi N; Yanagawa M; Tochigi H; Sakuma H; Kawamura J; Nakagawa T
Eur J Radiol; 1998 Feb; 26(3):290-6. PubMed ID: 9587759
[TBL] [Abstract][Full Text] [Related]
14. Development of a macromolecular dual-modality MR-optical imaging for sentinel lymph node mapping.
Melancon MP; Wang Y; Wen X; Bankson JA; Stephens LC; Jasser S; Gelovani JG; Myers JN; Li C
Invest Radiol; 2007 Aug; 42(8):569-78. PubMed ID: 17620940
[TBL] [Abstract][Full Text] [Related]
15. [Application of anoptomagnetic probe Gd-DO3A-EA-FITC in imaging and analyzing the brain interstitial space].
Li YQ; Sheng Y; Liang L; Zhao Y; Li HY; Bai N; Wang T; Yuan L; Han HB
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):221-225. PubMed ID: 29643518
[TBL] [Abstract][Full Text] [Related]
16. Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging.
Huang Y; Boamah PO; Gong J; Zhang Q; Hua M; Ye Y
Carbohydr Polym; 2016 Jun; 143():288-95. PubMed ID: 27083371
[TBL] [Abstract][Full Text] [Related]
17. Gadofluorine M-enhanced magnetic resonance imaging of inflammatory bowel disease: quantitative analysis and histologic correlation in a rat model.
Frericks BB; Kühl AA; Loddenkemper C; Stroux A; Valdeig S; Hotz B; Misselwitz B; Hoffmann JC; Wacker FK
Invest Radiol; 2011 Aug; 46(8):478-85. PubMed ID: 21512398
[TBL] [Abstract][Full Text] [Related]
18. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
19. In vivo microscopic evaluation of the microvascular behavior of FITC-labeled macromolecular MR contrast agents in the hamster skinfold chamber.
Schneider G; Seidel R; Uder M; Wagner D; Weinmann HJ; Kramann B
Invest Radiol; 2000 Sep; 35(9):564-70. PubMed ID: 10982002
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
